Literature DB >> 1608023

Glucose, insulin, HGH and IGF-I levels in maternal serum, amniotic fluid and umbilical venous serum: a comparison between late normal pregnancy and pregnancies complicated with diabetes and fetal growth retardation.

J Delmis1, A Drazancic, M Ivanisevic, E Suchanek.   

Abstract

Fetal growth and development is dependent upon various growth factors such as glucose, insulin, HGH and IGF-I. These growth factors were measured in maternal serum (MS), amniotic fluid (AF) and umbilical venous serum (UV) in late gestation in normal, insulin dependent diabetic pregnancies (IDDM) and in pregnancies complicated with intrauterine growth retardation (IUGR). The UV glucose values of 1.9 +/- 0.9 mmol/L and UV insulin values of 8.0 +/- 1.8 mU/L were the lowest in IUGR pregnancies, and the highest were in UV serum from IDDM pregnancies, and the difference was statistically significant for this two groups. IGF-I values in UV indicated that there was significant difference in IGF-I concentrations when both, IUGR and IDDM groups were compared to the controls. There was a parallel shift in AF and MS glucose and insulin concentration as birthweight increased. The highest IGF-I values of 7.2 +/- 9.6 mumol/L in AF and MS were found in pregnancies with infants whose birthweight was 3500 grams and greater. Infants from pregnancies complicated with IUGR and IGF-I low values of 0.6 +/- 1.2 mumol/L in AF. HGH concentrations of 15.6 +/- 9.4 micrograms/L in UV were observed in IDDM pregnancies and significantly lower than the values in IUGR and normal pregnancies. HGH umbilical venous values decreased with duration of pregnancy and with increase in fetal size. The high HGH concentrations in the fetus and its dramatic fall after parturition, and the obtained negative correlation between HGH and IGF-I in umbilical vein may exhibit the maturation of the hypothalamic-growth hormone-IGF-I axis. It seems likely that changes in maternal serum, umbilical venous and amniotic fluid insulin-like growth factor I influence birthweight in normal and IUGR infants and in those of diabetic mothers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1608023     DOI: 10.1515/jpme.1992.20.1.47

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  5 in total

Review 1.  Big babies and infant leukemia: a role for insulin-like growth factor-1?

Authors:  J A Ross; J P Perentesis; L L Robison; S M Davies
Journal:  Cancer Causes Control       Date:  1996-09       Impact factor: 2.506

2.  Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: randomized placebo controlled clinical trial.

Authors:  M Horvaticek; J Djelmis; M Ivanisevic; S Oreskovic; M Herman
Journal:  Eur J Clin Nutr       Date:  2017-04-05       Impact factor: 4.016

Review 3.  Placental metabolic reprogramming: do changes in the mix of energy-generating substrates modulate fetal growth?

Authors:  Nicholas P Illsley; Isabella Caniggia; Stacy Zamudio
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

4.  Maternal exposure to UV filters: associations with maternal thyroid hormones, IGF-I/IGFBP3 and birth outcomes.

Authors:  M Krause; H Frederiksen; K Sundberg; F S Jørgensen; L N Jensen; P Nørgaard; C Jørgensen; P Ertberg; J H Petersen; U Feldt-Rasmussen; A Juul; K T Drzewiecki; N E Skakkebaek; A M Andersson
Journal:  Endocr Connect       Date:  2018-01-23       Impact factor: 3.335

5.  The effect of pre-pregnancy hair dye exposure on infant birth weight: a nested case-control study.

Authors:  Chao Jiang; Qingzhi Hou; Yaling Huang; Juan Ye; Xiaolian Qin; Yu Zhang; Wen Meng; Qiuyan Wang; Yonghua Jiang; Haiying Zhang; Mujun Li; Zengnan Mo; Xiaobo Yang
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-09       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.